Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allianz Global Investors is a premier global active asset manager that manages a significant portfolio of healthcare and life sciences investments. The firm operates specialized funds, such as the Allianz Global Healthcare Equity and Allianz Health Innovation strategies, which target transformative companies across the biotechnology, pharmaceutical, and medical technology sectors. By providing essential capital to both established industry leaders and emerging innovators, AllianzGI plays a critical role in the financial ecosystem of the healthcare industry. Their investment approach combines deep fundamental research with a long-term perspective on medical innovation and demographic trends. The company is a subsidiary of the global insurance giant Allianz SE and serves institutional and retail clients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allianz Global Investors.